Is Levemir still in shortage in 2026? Get the latest update on availability, cost, alternatives, and what you can do to keep your insulin supply steady.
If you depend on Levemir (Insulin Detemir) to manage your diabetes, you've probably noticed that it's gotten harder and harder to find. The shortage isn't new — it's been building since late 2024 — but in 2026, the situation has reached a critical point for many patients.
In this update, we'll cover the current status of the Levemir shortage, what's causing it, what it costs in 2026, what alternatives are available, and how you can still find it if you need it.
Yes. As of early 2026, Levemir remains in shortage across the United States. But "shortage" doesn't fully capture what's happening — Novo Nordisk, the sole manufacturer, is permanently discontinuing Levemir. This isn't a temporary manufacturing delay that will resolve itself. Production has been winding down since late 2024, and remaining inventory in the supply chain continues to shrink.
In the UK, authorities have warned that Levemir supplies are expected to be fully exhausted by December 2026. The U.S. is on a similar timeline, though exact dates vary by region and pharmacy.
Levemir was the 153rd most commonly prescribed medication in the U.S. in 2023, with over 3 million prescriptions filled that year. That's a lot of patients who need to find a new source — or a new insulin.
The shortage comes down to a few key factors:
For a deeper dive, see our full article on why Levemir is so hard to find.
If you can find Levemir, here's what you can expect to pay:
If cost is a concern, check out our guide on how to save money on Levemir.
If you can't find Levemir or if the cost has become too high, there are several effective long-acting insulin alternatives:
The most common replacement. Insulin Glargine is a once-daily long-acting insulin with a similar profile to Levemir. Biosimilar versions like Basaglar and Semglee are widely available and often cost $150 to $300 per box — significantly less than Levemir.
An ultra-long-acting insulin from Novo Nordisk that lasts over 42 hours. It offers more flexible dosing but costs $400 to $550 per box without insurance.
An intermediate-acting insulin that costs as little as $50 to $150 per vial. It requires twice-daily dosing and has a more pronounced peak, but it's widely available and affordable.
Read our full comparison in alternatives to Levemir.
The insulin landscape continues to evolve. A few developments worth watching in 2026:
If you're not ready to switch and want to find remaining Levemir inventory, here's your best approach:
For more detailed tips, see our guide on how to find Levemir in stock near you.
The Levemir shortage in 2026 is a direct result of the manufacturer's decision to discontinue the drug. It's not going to get better — it's going to end, as remaining supplies are used up.
The most important thing you can do right now is make a plan. If you're still on Levemir, talk to your doctor about transitioning to an alternative insulin before your supply runs out completely. If you need to find Levemir in the meantime, Medfinder can help you locate it.
Don't wait until you're on your last pen. Plan ahead, explore your options, and make sure you always have the insulin you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
